Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells

Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19380-5. doi: 10.1073/pnas.1213868109. Epub 2012 Nov 5.

Abstract

Major histocompatibility complex class II molecules (MHC-II) on antigen presenting cells (APCs) engage the TCR on antigen-specific CD4 T cells, thereby providing the specificity required for T cell priming and the induction of an effective immune response. In this study, we have asked whether antigen-loaded dendritic cells (DCs) that have been in contact with antigen-specific CD4 T cells retain the ability to stimulate additional naïve T cells. We show that encounter with antigen-specific primed CD4 T cells induces the degradation of surface MHC-II in antigen-loaded DCs and inhibits the ability of these DCs to stimulate additional naïve CD4 T cells. Cross-linking with MHC-II mAb as a surrogate for T-cell engagement also inhibits APC function and induces MHC-II degradation by promoting the clustering of MHC-II present in lipid raft membrane microdomains, a process that leads to MHC-II endocytosis and degradation in lysosomes. Encounter of DCs with antigen-specific primed T cells or engagement of MHC-II with antibodies promotes the degradation of both immunologically relevant and irrelevant MHC-II molecules. These data demonstrate that engagement of MHC-II on DCs after encounter with antigen-specific primed CD4 T cells promotes the down-regulation of cell surface MHC-II in DCs, thereby attenuating additional activation of naïve CD4 T cells by these APCs.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen-Presenting Cells / drug effects
  • Antigen-Presenting Cells / immunology
  • CD4 Antigens / immunology*
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cholesterol / metabolism
  • Cross-Linking Reagents / pharmacology
  • Cross-Priming / drug effects
  • Cross-Priming / immunology*
  • Dendritic Cells / cytology
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology*
  • Endocytosis / drug effects
  • Histocompatibility Antigens Class II / immunology*
  • Lysosomes / drug effects
  • Lysosomes / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Peptides / immunology
  • Proteolysis / drug effects

Substances

  • CD4 Antigens
  • Cross-Linking Reagents
  • Histocompatibility Antigens Class II
  • Peptides
  • Cholesterol